サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1623514

尿検査の世界市場規模：タイプ別、用途別、エンドユーザー別、地域別、範囲および予測

Global Urinalysis Market Size By Type (Instruments, Consumables), By Application (Disease Screening, Pregnancy and Fertility Testing), By End-User (Clinical Laboratories, Hospitals, Home Care), By Geographic Scope and Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
尿検査の世界市場規模：タイプ別、用途別、エンドユーザー別、地域別、範囲および予測
出版日: 2024年09月12日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

尿検査の市場規模と予測

尿検査市場規模は、2023年に20億7,000万米ドルと評価され、2031年には39億1,000万米ドルに達すると予測され、2024年から2031年までのCAGRは8.30%で成長します。尿検査とは、尿サンプルを検査して健康状態を評価し、疾患を検出し、様々な病状を監視する診断プロセスを指します。この分析は、尿路感染症、腎臓病、糖尿病、肝障害などの状態を診断するために、臨床検査室やヘルスケア現場で広く利用されています。

技術の進歩により、ポイントオブケア検査装置や自動尿検査システムの開発など、検査方法の革新が進んでおり、尿検査の将来は有望です。

尿検査の世界市場力学

世界の尿検査市場を形成している主な市場力学は以下の通り：

主な市場促進要因

尿路感染症（UTI）の発生率の上昇：

世界では毎年約1億5,000万件の尿路感染症が発生しており、これらの症状を効果的に診断・管理するための尿検査に対する大きな需要が生じています。

糖尿病の有病率の増加：

2021年現在、世界中で推定5億3,700万人の成人が糖尿病を患っており、グルコースレベルを監視し合併症を予防するための定期的な尿検査の必要性が高まっており、市場の成長をさらに促進しています。

技術の進歩：

ポイントオブケア検査機器の世界市場は2025年までに606億米ドルに達すると予測され、尿検査技術の革新が促進され、さまざまなヘルスケア環境での用途が拡大します。

予防ヘルスケアの重視：

2022年までに世界のヘルスケア支出は10兆ドルに達すると予測されており、政府や保健機関は予防ヘルスケアをますます推進しています。

主な課題

正確性と信頼性への懸念：

人為的ミスやサンプルの不適切な取り扱いによる結果のばらつきは、尿検査の精度に影響を及ぼし、臨床的な意思決定に課題をもたらします。

規制の遵守：

診断検査に関する厳しい規制基準やガイドラインは、新しい尿検査機器や技術の承認プロセスを複雑にする可能性があります。

先端技術の高コスト：

自動化された高度な尿検査システムの導入は、その高額なコストによって妨げられる可能性があり、小規模なヘルスケア施設ではアクセスが制限されます。

新興市場における認知度の低さ：

特に新興国市場では、ヘルスケアにおける尿検査の重要性に関する認識や教育が不足していることが多く、これが市場の成長を制限する可能性があります。

主要動向：

人工知能（AI）の統合：

AIと機械学習アルゴリズムの尿検査プロセスへの組み込みは、結果の解釈を強化し、診断精度を向上させ、ワークフローを合理化します。

在宅検査の台頭：

自宅での健康モニタリングソリューションに対する消費者の需要の高まりにより、自宅で快適に検査を実施できる使いやすい尿検査キットの開発が進んでいます。

個別化医療へのアプローチ：

個別化医療を目指す傾向が高まっており、尿検査がオーダーメイドのヘルスケア・プランに組み込まれることで、より良い疾病管理とモニタリングが可能になります。

遠隔医療サービスの拡大：

遠隔医療プラットフォームの台頭により、遠隔地からの診察やモニタリングが容易になり、尿検査サービスへのアクセスが向上し、健康状態へのタイムリーな介入や管理が可能になりつつあります。

目次

第1章 尿検査の世界市場イントロダクション

  • 市場の定義
  • 市場セグメンテーション
  • 調査スケジュール
  • 前提条件
  • 制限事項

第2章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • データの三角測量
  • ボトムアップアプローチ
  • トップダウンアプローチ
  • 調査の流れ
  • 業界専門家による主要な洞察
  • データソース

第3章 エグゼクティブサマリー

  • 市場概要
  • エコロジーのマッピング
  • 絶対的収益機会
  • 市場の魅力
  • 尿検査の世界市場地域別分析
  • 尿検査の世界市場：タイプ別
  • 尿検査の世界市場：用途別
  • 尿検査の世界市場：エンドユーザー別
  • 今後の市場機会
  • 世界市場内訳
  • 製品ライフライン

第4章 尿検査の世界市場展望

  • 尿検査の世界進化
  • 促進要因
  • 抑制要因
  • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析
  • 価格分析
  • マクロ経済分析

第5章 尿検査の世界市場：タイプ別

  • 概要
  • カートリッジとカプセル
  • シリンジフィルター
  • ボトルトップ真空フィルター
  • その他

第6章 尿検査の世界市場、用途別

  • 概要
  • 器具
  • 消耗品

第7章 尿検査の世界市場：エンドユーザー別

  • 概要
  • 臨床検査室
  • 病院
  • 在宅医療
  • その他

第8章 尿検査の世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 尿検査の世界市場の競合情勢

  • 概要
  • 企業市場ランキング
  • 主な発展
  • 企業の地域フットプリント
  • 企業の産業別フットプリント
  • ACEマトリックス

第10章 企業プロファイル

  • Cardinal Health
  • Roche Diagnostics
  • Sysmex Corporation
  • Beckman Coulter
  • Arkray Inc.Abbott
  • Siemens Healthcare GmbH
  • ACON Laboratories
  • Shenzhen Mindray Bio-Medical Electronics
  • F. Hoffmann-La Roche
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Urit Medical Electronics
  • 77 Elektronika Kft.
  • Mindray Medical International Limited

第11章 VERIFIED MARKET INTELLIGENCE

  • VERIFIED MARKET INTELLIGENCEについて
  • ダイナミックなデータの可視化
目次
Product Code: 23989

Urinalysis Market Size and Forecast

Urinalysis Market size was valued at USD 2.07 Billion in 2023 and is projected to reach USD 3.91 Billion by 2031 , growing at a CAGR of 8.30% from 2024 to 2031. urinalysis refers to a diagnostic process that examines urine samples to assess health status, detect diseases, and monitor various medical conditions. This analysis is widely utilized in clinical laboratories and healthcare settings for diagnosing conditions such as urinary tract infections, kidney diseases, diabetes, and liver disorders.

The future of urinalysis is promising, with advancements in technology driving innovation in testing methods, including the development of point-of-care testing devices and automated urinalysis systems.

Global Urinalysis Market Dynamics

The key market dynamics that are shaping the global urinalysis market include:

Key Market Drivers

Rising Incidence of Urinary Tract Infections (UTIs):

Approximately 150 million urinary tract infections occur globally each year, creating a significant demand for urinalysis to diagnose and manage these conditions effectively.

Growing Prevalence of Diabetes:

With an estimated 537 million adults worldwide living with diabetes as of 2021, the need for regular urinalysis to monitor glucose levels and prevent complications is increasing, further driving market growth.

Technological Advancements:

The global market for point-of-care testing devices is projected to reach $60.6 billion by 2025, fostering innovation in urinalysis technology and expanding its applications in various healthcare settings.

Emphasis on Preventive Healthcare:

Governments and health organizations are increasingly promoting preventive healthcare measures, with global healthcare expenditure projected to reach $10 trillion by 2022, which supports the growth of routine diagnostic tests, including urinalysis.

Key Challenges

Accuracy and Reliability Concerns:

Variability in results due to human error or improper sample handling can affect the accuracy of urinalysis, posing challenges in clinical decision-making.

Regulatory Compliance:

Stringent regulatory standards and guidelines for diagnostic tests can complicate the approval process for new urinalysis devices and technologies.

High Cost of Advanced Technologies:

The adoption of automated and advanced urinalysis systems can be hindered by their high costs, limiting access for smaller healthcare facilities.

Limited Awareness in Emerging Markets:

There is often a lack of awareness and education regarding the importance of urinalysis in healthcare, particularly in developing regions, which can restrict market growth.

Key Trends:

Integration of Artificial Intelligence (AI):

The incorporation of AI and machine learning algorithms into urinalysis processes is enhancing the interpretation of results, improving diagnostic accuracy, and streamlining workflows.

Rise of Home-Based Testing:

Increasing consumer demand for at-home health monitoring solutions is leading to the development of user-friendly urinalysis kits that allow individuals to conduct tests in the comfort of their homes.

Personalized Medicine Approaches:

There is a growing trend towards personalized medicine, where urinalysis is being integrated into tailored healthcare plans, enabling better disease management and monitoring.

Expansion of Telehealth Services:

The rise of telehealth platforms is facilitating remote consultations and monitoring, increasing the accessibility of urinalysis services and allowing for timely intervention and management of health conditions.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Urinalysis Market Regional Analysis

Here is a more detailed regional analysis of the global urinalysis market:

North America:

North America is the dominant region in the global urinalysis market, accounting for a significant share due to its well-established healthcare infrastructure, advanced diagnostic technologies, and high awareness of preventive healthcare. The region's strong emphasis on early disease detection and management contributes to the widespread adoption of urinalysis tests in clinical settings. According to the Centers for Disease Control and Prevention (CDC), approximately 70% of all healthcare decisions are based on laboratory test results, highlighting the critical role of urinalysis in patient care.

The presence of major market players, robust research and development activities, and a strong regulatory framework further enhance North America's market position. The U.S. Food and Drug Administration (FDA) has approved numerous innovative urinalysis products, ensuring that healthcare providers have access to advanced testing solutions. The region's focus on personalized medicine and rapid technological advancements, including point-of-care testing, also bolster the growth of the urinalysis market.

Asia Pacific:

The Asia Pacific region is the fastest-growing market for urinalysis, driven by a combination of increasing healthcare expenditures, a rising population, and growing awareness of preventive healthcare measures. Rapid urbanization and economic growth in countries like China and India have led to a surge in demand for diagnostic testing services, including urinalysis. According to the World Health Organization (WHO), healthcare spending in Asia Pacific is projected to reach $2.4 trillion by 2025, reflecting a strong commitment to improving healthcare access and quality.

The rising prevalence of lifestyle-related diseases, such as diabetes, hypertension, and obesity, is further propelling the demand for urinalysis in the region. For instance, the International Diabetes Federation (IDF) estimates that the number of adults with diabetes in the Asia Pacific region will rise to over 200 million by 2030, necessitating regular monitoring through urinalysis. This growing disease burden creates significant opportunities for market players to introduce innovative testing solutions tailored to the region's specific health challenges.

Global Urinalysis Market Segmentation Analysis

The Global Urinalysis Market is segmented on the basis of By Type, By Application, By End User and By Geography.

Urinalysis Market, By Type

  • Instruments
  • Consumables

Based on Type, the Global Urinalysis Market is segmented into Instruments and Consumables. The Instruments is the dominate segment due to the widespread adoption of automated urinalysis systems and analyzers in hospitals and diagnostic laboratories. These instruments offer enhanced accuracy and efficiency in urine testing, making them a crucial part of the diagnostic process. However, the consumables segment is the fastest-growing, driven by the rising demand for test strips, reagents, and disposable items used in both traditional and point-of-care testing.

Urinalysis Market, By Application

  • Disease Screening
  • Pregnancy and Fertility Kits

Based on Application, the Global Urinalysis Market is segmented into Disease Screening and Pregnancy & Fertility Kits. The disease screening segment is the dominant segment, driven by its widespread use in detecting conditions such as urinary tract infections, kidney disorders, and diabetes. On the other hand, the pregnancy and fertility kits segment is the fastest-growing, owing to the increasing demand for at-home testing kits that offer convenience and privacy.

Urinalysis Market, By End User

  • Clinical Laboratories
  • Hospitals
  • Home Care

Based on End User, the Global Urinalysis Market is segmented into Disease Screening and Pregnancy & Fertility Kits. The clinical laboratories is the dominating segment due to the widespread use of advanced diagnostic equipment and the high volume of tests conducted in these facilities. On the other hand, the home care segment is the fastest-growing, driven by the increasing demand for at-home diagnostic solutions and the rise of point-of-care testing.

Urinalysis Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Urinalysis Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the global urinalysis market, accounting for a significant share due to its well-established healthcare infrastructure, advanced diagnostic technologies, and high awareness of preventive healthcare. The Asia Pacific region is the fastest-growing market for urinalysis, driven by a combination of increasing healthcare expenditures, a rising population, and growing awareness of preventive healthcare measures.

Key Players

  • The "Global Urinalysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
  • Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific, Bayer AG, F. Hoffmann-La Roche Ltd, Beckman Coulter Life Sciences, Alfa Wassermann Inc., EKF Diagnostics, Trinity Biotech plc, Arkray, Mindray Medical International Limited, and more.
  • Our
  • market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
  • Global Urinalysis Market: Recent Developments
  • In August 2023 Siemens Healthineers announced its acquisition of a cutting-edge urinalysis technology firm focused on developing point-of-care testing solutions.
  • In July 2023 Becton, Dickinson and Company (BD) launched a new line of enhanced urinalysis reagents, designed to improve the sensitivity and specificity of urinalysis tests.
  • In June 2023 Abbott announced a strategic partnership with a HealthTech startup specializing in digital health solutions for urinalysis. This collaboration aims to develop a mobile application that allows patients to conduct at-home urinalysis tests and receive real-time feedback on their results.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL URINALYSIS MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Urinalysis Market Geographical Analysis (CAGR %)
  • 3.6 Global Urinalysis Market, By Type (USD Million)
  • 3.7 Global Urinalysis Market, By Application (USD Million)
  • 3.8 Global Urinalysis Market, By End-User (USD Million)
  • 3.9 Future Market Opportunities
  • 3.10 Global Market Split
  • 3.11 Product Life Line

4 GLOBAL URINALYSIS MARKET OUTLOOK

  • 4.1 Global Urinalysis Evolution
  • 4.2 Drivers
    • 4.2.1 Driver 1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint 1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity 1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL URINALYSIS MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Cartridges & Capsules
  • 5.3 Syringe Filters
  • 5.4 Bottle-Top Vacuum Filters
  • 5.5 Others

6 GLOBAL URINALYSIS MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Instruments
  • 6.3 Consumables

7 GLOBAL URINALYSIS MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Clinical Laboratories
  • 7.3 Hospitals
  • 7.4 Home Care
  • 7.5 Others

8 GLOBAL URINALYSIS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
    • 8.5.3 Rest of Latin America
  • 8.6 Middle-East and Africa
    • 8.6.1 UAE
    • 8.6.2 Saudi Arabia
    • 8.6.3 South Africa
    • 8.6.4 Rest of Middle-East and Africa

9 GLOBAL URINALYSIS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Developments
  • 9.4 Company Regional Footprint
  • 9.5 Company Industry Footprint
  • 9.6 ACE Matrix

10 COMPANY PROFILES

  • 10.1 Cardinal Health
    • 10.1.1 Company Overview
    • 10.1.2 Company Insights
    • 10.1.3 Product Benchmarking
    • 10.1.4 Key Development
    • 10.1.5 Winning Imperatives
    • 10.1.6 Current Focus & Strategies
    • 10.1.7 Threat from Competition
    • 10.1.8 SWOT Analysis
  • 10.2 Roche Diagnostics
    • 10.2.1 Company Overview
    • 10.2.2 Company Insights
    • 10.2.3 Product Benchmarking
    • 10.2.4 Key Development
    • 10.2.5 Winning Imperatives
    • 10.2.6 Current Focus & Strategies
    • 10.2.7 Threat from Competition
    • 10.2.8 SWOT Analysis
  • 10.3 Sysmex Corporation
    • 10.3.1 Company Overview
    • 10.3.2 Company Insights
    • 10.3.3 Product Benchmarking
    • 10.3.4 Key Development
    • 10.3.5 Winning Imperatives
    • 10.3.6 Current Focus & Strategies
    • 10.3.7 Threat from Competition
    • 10.3.8 SWOT Analysis
  • 10.4 Beckman Coulter
    • 10.4.1 Company Overview
    • 10.4.2 Company Insights
    • 10.4.3 Product Benchmarking
    • 10.4.4 Key Development
    • 10.4.5 Winning Imperatives
    • 10.4.6 Current Focus & Strategies
    • 10.4.7 Threat from Competition
    • 10.4.8 SWOT Analysis
  • 10.5 Arkray Inc.Abbott
    • 10.5.1 Company Overview
    • 10.5.2 Company Insights
    • 10.5.3 Product Benchmarking
    • 10.5.4 Key Development
    • 10.5.5 Winning Imperatives
    • 10.5.6 Current Focus & Strategies
    • 10.5.7 Threat from Competition
    • 10.5.8 SWOT Analysis
  • 10.6 Siemens Healthcare GmbH
    • 10.6.1 Company Overview
    • 10.6.2 Company Insights
    • 10.6.3 Product Benchmarking
    • 10.6.4 Key Development
    • 10.6.5 Winning Imperatives
    • 10.6.6 Current Focus & Strategies
    • 10.6.7 Threat from Competition
    • 10.6.8 SWOT Analysis
  • 10.7 ACON Laboratories
    • 10.7.1 Company Overview
    • 10.7.2 Company Insights
    • 10.7.3 Product Benchmarking
    • 10.7.4 Key Development
    • 10.7.5 Winning Imperatives
    • 10.7.6 Current Focus & Strategies
    • 10.7.7 Threat from Competition
    • 10.7.8 SWOT Analysis
  • 10.8 Shenzhen Mindray Bio-Medical Electronics
    • 10.8.1 Company Overview
    • 10.8.2 Company Insights
    • 10.8.3 Product Benchmarking
    • 10.8.4 Key Development
    • 10.8.5 Winning Imperatives
    • 10.8.6 Current Focus & Strategies
    • 10.8.7 Threat from Competition
    • 10.8.8 SWOT Analysis
  • 10.9 F. Hoffmann-La Roche
    • 10.9.1 Company Overview
    • 10.9.2 Company Insights
    • 10.9.3 Product Benchmarking
    • 10.9.4 Key Development
    • 10.9.5 Winning Imperatives
    • 10.9.6 Current Focus & Strategies
    • 10.9.7 Threat from Competition
    • 10.9.8 SWOT Analysis
  • 10.10 Quidel Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Insights
    • 10.10.3 Product Benchmarking
    • 10.10.4 Key Development
    • 10.10.5 Winning Imperatives
    • 10.10.6 Current Focus & Strategies
    • 10.10.7 Threat from Competition
    • 10.10.8 SWOT Analysis
  • 10.11 Bio-Rad Laboratories
    • 10.11.1 Company Overview
    • 10.11.2 Company Insights
    • 10.11.3 Product Benchmarking
    • 10.11.4 Key Development
    • 10.11.5 Winning Imperatives
    • 10.11.6 Current Focus & Strategies
    • 10.11.7 Threat from Competition
    • 10.11.8 SWOT Analysis
  • 10.12 Urit Medical Electronics
    • 10.12.1 Company Overview
    • 10.12.2 Company Insights
    • 10.12.3 Product Benchmarking
    • 10.12.4 Key Development
    • 10.12.5 Winning Imperatives
    • 10.12.6 Current Focus & Strategies
    • 10.12.7 Threat from Competition
    • 10.12.8 SWOT Analysis
  • 10.13 77 Elektronika Kft.
    • 10.13.1 Company Overview
    • 10.13.2 Company Insights
    • 10.13.3 Product Benchmarking
    • 10.13.4 Key Development
    • 10.13.5 Winning Imperatives
    • 10.13.6 Current Focus & Strategies
    • 10.13.7 Threat from Competition
    • 10.13.8 SWOT Analysis
  • 10.14 Mindray Medical International Limited
    • 10.14.1 Company Overview
    • 10.14.2 Company Insights
    • 10.14.3 Product Benchmarking
    • 10.14.4 Key Development
    • 10.14.5 Winning Imperatives
    • 10.14.6 Current Focus & Strategies
    • 10.14.7 Threat from Competition
    • 10.14.8 SWOT Analysis

11. VERIFIED MARKET INTELLIGENCE

  • 11.1 About Verified Market Intelligence
  • 11.2 Dynamic Data Visualization